212 related articles for article (PubMed ID: 22388726)
41. Allelotype analysis in relapsed childhood acute lymphoblastic leukemia.
Takeuchi S; Seriu T; van Dongen JJ; Szczepański T; Tsukasaki K; Takeuchi N; Fermin AC; Seo H; Bartram CR; Koeffler HP
Oncogene; 2003 Oct; 22(44):6970-6. PubMed ID: 14534546
[TBL] [Abstract][Full Text] [Related]
42. FLT3 mutations in childhood acute lymphoblastic leukemia.
Armstrong SA; Mabon ME; Silverman LB; Li A; Gribben JG; Fox EA; Sallan SE; Korsmeyer SJ
Blood; 2004 May; 103(9):3544-6. PubMed ID: 14670924
[TBL] [Abstract][Full Text] [Related]
43. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
44. Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
Tamai M; Kasai S; Akahane K; Thu TN; Kagami K; Komatsu C; Abe M; Watanabe A; Goi K; Miyake K; Inaba T; Takita J; Goto H; Minegishi M; Iwamoto S; Sugita K; Inukai T
J Steroid Biochem Mol Biol; 2022 Apr; 218():106068. PubMed ID: 35124168
[TBL] [Abstract][Full Text] [Related]
45. Adult acute lymphoblastic leukemia with near haploidy, hyperdiploidy and Ph positive lines: a rare entity with poor prognosis.
Sunil SK; Prakash PN; Hariharan S; Vinod G; Preethi RT; Geetha N; Ankathil R
Leuk Lymphoma; 2006 Mar; 47(3):561-3. PubMed ID: 16396782
[TBL] [Abstract][Full Text] [Related]
46. Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.
Bokemeyer A; Eckert C; Meyr F; Koerner G; von Stackelberg A; Ullmann R; Türkmen S; Henze G; Seeger K
Haematologica; 2014 Apr; 99(4):706-14. PubMed ID: 24241490
[TBL] [Abstract][Full Text] [Related]
47. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
[TBL] [Abstract][Full Text] [Related]
48. Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia.
Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Fischer U; Dugas M; Hu J; Borkhardt A
Genes Chromosomes Cancer; 2013 Jun; 52(6):564-79. PubMed ID: 23508829
[TBL] [Abstract][Full Text] [Related]
49. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
[TBL] [Abstract][Full Text] [Related]
50. Hyperdiploidy arising from near-haploidy in childhood acute lymphoblastic leukemia.
Onodera N; McCabe NR; Nachman JB; Johnson FL; Le Beau MM; Rowley JD; Rubin CM
Genes Chromosomes Cancer; 1992 Jun; 4(4):331-6. PubMed ID: 1377941
[TBL] [Abstract][Full Text] [Related]
51. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
52. Mitochondrial D-loop polymorphisms and mitochondrial DNA content in childhood acute lymphoblastic leukemia.
Kwok CS; Quah TC; Ariffin H; Tay SK; Yeoh AE
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e239-44. PubMed ID: 21646920
[TBL] [Abstract][Full Text] [Related]
53. The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations.
Forestier E; Schmiegelow K;
J Pediatr Hematol Oncol; 2006 Aug; 28(8):486-95. PubMed ID: 16912588
[TBL] [Abstract][Full Text] [Related]
54. TP53 alterations in relapsed childhood acute lymphoblastic leukemia.
Yu CH; Chang WT; Jou ST; Lin TK; Chang YH; Lin CY; Lin KH; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Su YN; Hung CC; Lin DT; Chen HY; Yang YL
Cancer Sci; 2020 Jan; 111(1):229-238. PubMed ID: 31729120
[TBL] [Abstract][Full Text] [Related]
55. Genetic drivers of vulnerability and resistance in relapsed acute lymphoblastic leukemia.
Lu SX; Abdel-Wahab O
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11071-11073. PubMed ID: 27663730
[No Abstract] [Full Text] [Related]
56. Identification and Characterization of Novel Fusion Genes with Potential Clinical Applications in Mexican Children with Acute Lymphoblastic Leukemia.
Mata-Rocha M; Rangel-López A; Jiménez-Hernández E; Morales-Castillo BA; González-Torres C; Gaytan-Cervantes J; Álvarez-Olmos E; Núñez-Enríquez JC; Fajardo-Gutiérrez A; Martín-Trejo JA; Solís-Labastida KA; Medina-Sansón A; Flores-Lujano J; Sepúlveda-Robles OA; Peñaloza-González JG; Espinoza-Hernández LE; Núñez-Villegas NN; Espinosa-Elizondo RM; Cortés-Herrera B; Torres-Nava JR; Flores-Villegas LV; Merino-Pasaye LE; Bekker-Méndez VC; Velázquez-Aviña MM; Pérez-Saldívar ML; Bautista-Martínez BA; Amador-Sánchez R; González-Avila AI; Jiménez-Morales S; Duarte-Rodríguez DA; Santillán-Juárez JD; García-Velázquez AJ; Rosas-Vargas H; Mejía-Aranguré JM
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096545
[TBL] [Abstract][Full Text] [Related]
57. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; Slater RM; von dem Borne AE; van der Schoot CE
Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
[TBL] [Abstract][Full Text] [Related]
58. Microarray testing as an efficient tool to redefine hyperdiploid paediatric B-cell precursor acute lymphoblastic leukaemia patients.
Lejman M; Zawitkowska J; Styka B; Babicz M; Winnicka D; Zaucha-Prażmo A; Pastorczak A; Taha J; Młynarski W; Kowalczyk JR
Leuk Res; 2019 Aug; 83():106163. PubMed ID: 31202078
[TBL] [Abstract][Full Text] [Related]
59. Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.
Meyer JA; Wang J; Hogan LE; Yang JJ; Dandekar S; Patel JP; Tang Z; Zumbo P; Li S; Zavadil J; Levine RL; Cardozo T; Hunger SP; Raetz EA; Evans WE; Morrison DJ; Mason CE; Carroll WL
Nat Genet; 2013 Mar; 45(3):290-4. PubMed ID: 23377183
[TBL] [Abstract][Full Text] [Related]
60. DNMT3A mutations and prognostic significance in childhood acute lymphoblastic leukemia.
Li W; Gao C; Cui L; Liu S; Zhao X; Zhang R; Wu M; Zheng H; Deng G; Li Z; Zhang Q
Leuk Lymphoma; 2015 Apr; 56(4):1066-71. PubMed ID: 25242092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
